High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer

Long-term results of a radiation dose escalation study

Feng Ming Kong, Randall K. Ten Haken, Matthew J. Schipper, Molly A. Sullivan, Ming Chen, Carlos Lopez, Gregory P. Kalemkerian, James A. Hayman

Research output: Contribution to journalArticle

366 Citations (Scopus)

Abstract

Purpose: To determine whether high-dose radiation leads to improved outcomes in patients with non-small-cell lung cancer (NSCLC). Methods and Materials: This analysis included 106 patients with newly diagnosed or recurrent Stages I-III NSCLC, treated with 63-103 Gy in 2.1-Gy fractions, using three-dimensional conformal radiation therapy (3D-CRT) per a dose escalation trial. Targets included the primary tumor and any lymph nodes <1 cm, without intentionally including negative nodal regions. Nineteen percent of patients (20/106) received neoadjuvant chemotherapy. Patient, tumor, and treatment factors were evaluated for association with outcomes. Estimated median follow-up was 8.5 years. Results: Median survival was 19 months, and 5-year overall survival (OS) was 13%. Multivariate analysis revealed weight loss (p = 0.011) and radiation dose (p = 0.0006) were significant predictors for OS. The 5-year OS was 4%, 22%, and 28% for patients receiving 63-69, 74-84, and 92-103 Gy, respectively. Although presence of nodal disease was negatively associated with locoregional control under univariate analysis, radiation dose was the only significant predictor when multiple variables were included (p = 0.015). The 5-year control rate was 12%, 35%, and 49% for 63-69, 74-84, and 92-103 Gy, respectively. Conclusions: Higher dose radiation is associated with improved outcomes in patients with NSCLC treated in the range of 63-103 Gy.

Original languageEnglish (US)
Pages (from-to)324-333
Number of pages10
JournalInternational Journal of Radiation Oncology Biology Physics
Volume63
Issue number2
DOIs
StatePublished - Oct 1 2005

Fingerprint

Non-Small Cell Lung Carcinoma
lungs
tumors
cancer
Radiation
dosage
Survival
radiation
Neoplasms
weight analysis
lymphatic system
chemotherapy
predictions
Weight Loss
radiation therapy
Radiotherapy
Multivariate Analysis
Lymph Nodes
Drug Therapy

Keywords

  • High dose
  • Local control
  • Non-small-cell lung cancer
  • Survival
  • Three-dimensional conformal radiation therapy

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer : Long-term results of a radiation dose escalation study. / Kong, Feng Ming; Ten Haken, Randall K.; Schipper, Matthew J.; Sullivan, Molly A.; Chen, Ming; Lopez, Carlos; Kalemkerian, Gregory P.; Hayman, James A.

In: International Journal of Radiation Oncology Biology Physics, Vol. 63, No. 2, 01.10.2005, p. 324-333.

Research output: Contribution to journalArticle

Kong, Feng Ming ; Ten Haken, Randall K. ; Schipper, Matthew J. ; Sullivan, Molly A. ; Chen, Ming ; Lopez, Carlos ; Kalemkerian, Gregory P. ; Hayman, James A. / High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer : Long-term results of a radiation dose escalation study. In: International Journal of Radiation Oncology Biology Physics. 2005 ; Vol. 63, No. 2. pp. 324-333.
@article{d97bf2817e584e7f9a4b28e942736627,
title = "High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study",
abstract = "Purpose: To determine whether high-dose radiation leads to improved outcomes in patients with non-small-cell lung cancer (NSCLC). Methods and Materials: This analysis included 106 patients with newly diagnosed or recurrent Stages I-III NSCLC, treated with 63-103 Gy in 2.1-Gy fractions, using three-dimensional conformal radiation therapy (3D-CRT) per a dose escalation trial. Targets included the primary tumor and any lymph nodes <1 cm, without intentionally including negative nodal regions. Nineteen percent of patients (20/106) received neoadjuvant chemotherapy. Patient, tumor, and treatment factors were evaluated for association with outcomes. Estimated median follow-up was 8.5 years. Results: Median survival was 19 months, and 5-year overall survival (OS) was 13{\%}. Multivariate analysis revealed weight loss (p = 0.011) and radiation dose (p = 0.0006) were significant predictors for OS. The 5-year OS was 4{\%}, 22{\%}, and 28{\%} for patients receiving 63-69, 74-84, and 92-103 Gy, respectively. Although presence of nodal disease was negatively associated with locoregional control under univariate analysis, radiation dose was the only significant predictor when multiple variables were included (p = 0.015). The 5-year control rate was 12{\%}, 35{\%}, and 49{\%} for 63-69, 74-84, and 92-103 Gy, respectively. Conclusions: Higher dose radiation is associated with improved outcomes in patients with NSCLC treated in the range of 63-103 Gy.",
keywords = "High dose, Local control, Non-small-cell lung cancer, Survival, Three-dimensional conformal radiation therapy",
author = "Kong, {Feng Ming} and {Ten Haken}, {Randall K.} and Schipper, {Matthew J.} and Sullivan, {Molly A.} and Ming Chen and Carlos Lopez and Kalemkerian, {Gregory P.} and Hayman, {James A.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.ijrobp.2005.02.010",
language = "English (US)",
volume = "63",
pages = "324--333",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer

T2 - Long-term results of a radiation dose escalation study

AU - Kong, Feng Ming

AU - Ten Haken, Randall K.

AU - Schipper, Matthew J.

AU - Sullivan, Molly A.

AU - Chen, Ming

AU - Lopez, Carlos

AU - Kalemkerian, Gregory P.

AU - Hayman, James A.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Purpose: To determine whether high-dose radiation leads to improved outcomes in patients with non-small-cell lung cancer (NSCLC). Methods and Materials: This analysis included 106 patients with newly diagnosed or recurrent Stages I-III NSCLC, treated with 63-103 Gy in 2.1-Gy fractions, using three-dimensional conformal radiation therapy (3D-CRT) per a dose escalation trial. Targets included the primary tumor and any lymph nodes <1 cm, without intentionally including negative nodal regions. Nineteen percent of patients (20/106) received neoadjuvant chemotherapy. Patient, tumor, and treatment factors were evaluated for association with outcomes. Estimated median follow-up was 8.5 years. Results: Median survival was 19 months, and 5-year overall survival (OS) was 13%. Multivariate analysis revealed weight loss (p = 0.011) and radiation dose (p = 0.0006) were significant predictors for OS. The 5-year OS was 4%, 22%, and 28% for patients receiving 63-69, 74-84, and 92-103 Gy, respectively. Although presence of nodal disease was negatively associated with locoregional control under univariate analysis, radiation dose was the only significant predictor when multiple variables were included (p = 0.015). The 5-year control rate was 12%, 35%, and 49% for 63-69, 74-84, and 92-103 Gy, respectively. Conclusions: Higher dose radiation is associated with improved outcomes in patients with NSCLC treated in the range of 63-103 Gy.

AB - Purpose: To determine whether high-dose radiation leads to improved outcomes in patients with non-small-cell lung cancer (NSCLC). Methods and Materials: This analysis included 106 patients with newly diagnosed or recurrent Stages I-III NSCLC, treated with 63-103 Gy in 2.1-Gy fractions, using three-dimensional conformal radiation therapy (3D-CRT) per a dose escalation trial. Targets included the primary tumor and any lymph nodes <1 cm, without intentionally including negative nodal regions. Nineteen percent of patients (20/106) received neoadjuvant chemotherapy. Patient, tumor, and treatment factors were evaluated for association with outcomes. Estimated median follow-up was 8.5 years. Results: Median survival was 19 months, and 5-year overall survival (OS) was 13%. Multivariate analysis revealed weight loss (p = 0.011) and radiation dose (p = 0.0006) were significant predictors for OS. The 5-year OS was 4%, 22%, and 28% for patients receiving 63-69, 74-84, and 92-103 Gy, respectively. Although presence of nodal disease was negatively associated with locoregional control under univariate analysis, radiation dose was the only significant predictor when multiple variables were included (p = 0.015). The 5-year control rate was 12%, 35%, and 49% for 63-69, 74-84, and 92-103 Gy, respectively. Conclusions: Higher dose radiation is associated with improved outcomes in patients with NSCLC treated in the range of 63-103 Gy.

KW - High dose

KW - Local control

KW - Non-small-cell lung cancer

KW - Survival

KW - Three-dimensional conformal radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=24944432301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944432301&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2005.02.010

DO - 10.1016/j.ijrobp.2005.02.010

M3 - Article

VL - 63

SP - 324

EP - 333

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -